Autoimmune Disease Patient Education Panel
The Hackensack NJ Support Group of the Tri-State Scleroderma Foundation is sponsoring an Autoimmune Disease Patient Education Panel
FDA Approves Drug to Treat Lupus
Good news for fellow Frosties with Lupus! HEALTH INDUSTRY MARCH 9, 2011, 6:22 P.M. ET Wall Street Journal The Food and Drug Administration approved a new lupus drug from Human Genome Sciences Inc. and GlaxoSmithKline PLC, marking the first new treatment for the autoimmune disease in more than 50 years.
Sildenafil (Viagra) Reduces Raynaud’s Frequency in Patients with Scleroderma
Modified-Release Therapy is Well Tolerated in Clinical Trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor
Who controls the thermostat in your home?
Sound Familiar??? http://www.cnn.com/2011/HEALTH/03/02/thermostat.arguments/
Today is Rare Disease Day!
Rare Disease Day was established in 2008 to raise awareness about rare diseases, which together impact millions of people worldwide. While the Raynaud’s population is too large to be considered in this category, many among us with secondary Raynaud’s suffer from these rare medical conditions.